Saving changes...

Done

Error

Injectable Combination Therapies for the Management of Diabetes: A Guide for Health Care Decision Makers

Injectable Combination Therapies for the Management of Diabetes: A Guide for Health Care Decision Makers

Injectable Combination Therapies for the Management of Diabetes: A Guide for Health Care Decision Makers

Vanita R. Aroda, MD
Vanita R. Aroda, MD
on behalf of Postgraduate Healthcare Education, LLC

FREE
FREE
FREE

FREE
FREE
FREE

null FREE
FREE
FREE
null FREE
FREE
FREE
Normal Price: FREE FREE

Review:

Launch date: 13 Mar 2017
Expiry Date:

Last updated: 15 Mar 2017

Reference: 172095

This course is no longer available

Exam is embedded in the course
No preview available
No Exam Available

Latest User Comments

I would like to...

Course Availability

This course is only available to trainees days after purchase. It would need to be repurchased by the trainee if not completed in the allotted time period. This course is no longer available. You will need to repurchase if you wish to take the course again.

You have null days left.

Description

Diabetes mellitus is a chronic progressive disease affecting an estimated 30 million Americans—nearly one in every ten persons—and its prevalence continues to increase with 1.4 million Americans newly diagnosed each year. Patients with type 2 diabetes mellitus (T2DM) represent 90%-95% of cases. Diabetes is associated with elevated risk for complications such as kidney failure, blindness, and lower limb amputations, comorbidities including hypertension and dyslipidemia, and increased cardiovascular mortality all of which lead to increased medical costs and indirect costs from work-related absenteeism, reduced productivity, and premature mortality. This activity highlights opportunities for health care decision makers (HCDMs) to improve the management of T2DM for their health plan members by implementing and/or recommending evidence-based practice recommendations within the framework of published treatment guidelines and patient-centered care.

Objectives

Objectives
After completing this activity, the participant should be better able to:

-Assess emerging and recently approved insulin-based combination therapies for the treatment of T2DM and cite their clinical trial data.
-Apply strategies to increase coordination of diabetes care among multidisciplinary teams within the managed care setting.
-Review a patient-centered approach for T2DM management and improved adherence to treatment.
-Recommend a benefit design strategy that payers can implement to improve clinical outcomes and the overall value of T2DM management.
Vanita R. Aroda, MD

Author Information Play Video Bio

Vanita R. Aroda, MD
on behalf of Postgraduate Healthcare Education, LLC

Vanita R. Aroda, MD Scientific Director, Physician Investigator MedStar Community Clinical Research Center Associate Professor of Medicine, Endocrinology, Diabetes, and Metabolism Georgetown University School of Medicine Jeffrey Dunn, PharmD, MBA Senior Vice President Chief Clinical Officer VRx/MagellanRx Edmund Pezalla, MD, MPH CEO Enlightenment Bioconsulting

Current Accreditations

This course has been certified by or provided by the following Certified Organization/s:

  • Accreditation Council for Pharmacy Education (ACPE)
  • 0.50 Hours -
    Exam Pass Rate: 75
    -
    Reference: 0816-9999-17-080-H01-P

Faculty and Disclosures

Additional Contributors

null

Conflicts Declared

Conflicts of Interest declaration by Author:

null

User Reviews (0)

Go Back

Loading...


Saving changes...

Done

Error